A form of systemic tetanus with atypical symptoms was observed in mice injected in the left thigh with a mixture of tetanus toxin and antibody produced in guinea pigs against a fragment of toxin obtained from a subtilisin digest of the crystallized toxin. The mice did not show typical symptoms of the local tetanus such as convulsions or spastic paralysis of the injected limb.
Several studies have shown that extracellular tetanus toxin consists of two polypeptide chains, heavy and light, with molecular weights of about 100,000 and 50,000, respectively. These fragments result from proteolytic nicking of intracellular toxin composed of a single polypeptide chain with a molecular weight of about 150,000 (1, 2, 6) . On the basis of immunochemical studies with antibodies to fragments obtained by treating tetanus toxin with proteases or denaturants, the structural relationship among the fragments was clarified, and a schematic model of antigenic structure of the toxin was proposed (1, 4, 6, 7, 9) .
However, there are only a few reports concerning the relationship of toxin fragments to the mechanism of action of the toxin. Helting and Zwisler (4), using papain digestion of the toxin, isolated fragment C (molecular weight, 50,000) and fragment B (molecular weight, 100,000) and subsequently reported (5) that a binding site for ganglioside was located on the heavy chain of the toxin, possibly in or near the region comprised by fragment C. Helting et al. (3) found that mice injected with a large amount of fragment B exhibited a peculiar retraction of the abdominal muscles, but never gave the typical features of tetanus.
We now report that tetanus without local symptoms was observed in mice injected into the left thigh with a mixture of tetanus toxin and antibody against a 50,000-molecular-weight fragment (named fragment S) obtained after subtilisin digestion of the tetanus toxin. This fragment S may correspond to fragment C as described above (3, 4 dium. The culture filtrate was obtained from Takeda Chemical Ind., Ltd. (Hikari, Japan). The culture filtrate concentrated by ultrafiltration through Hollow Fiber (Amicon HIDP 10) was fractionated with ammonium sulfate between 20 and 40% saturation. The fractionated toxin was applied to a column of DE 52 (Whatman) equilibrated with 0.05 M tris(hydroxymethyl)aminomethane-hydrochloride (Tris-hydrochloride) buffer, pH 7.5. The column was washed with several column volumes of the buffer, and then the toxin was eluted with the buffer containing 0.03 M NaCl. Both activity and protein were found in two adjacent peaks. The two active fractions were pooled separately, and each of these purified fractions showed single bands with identical electrophoretic mobilities in disc electrophoresis. They also had almost the same specific activity in flocculating units per absorbance at 280 nm (A280) and 50% lethal dose per A280.
Crystallization of the purified toxin was done with each of the above active fractions. 24, 1979 tained within 20 days. For recrystallization, the crystals were dissolved in the minimal amount of 0.05 M phosphate buffer (pH 7.5). The powdered ammonium sulfate and saturated ammonium sulfate solution were carefully added as described above, and a few seed crystals of the toxin were added. The mixture was kept in the refrigerator. The crystalline tetanus toxin of about 20 ,um in length was obtained within 3 days (Fig. 1) . The crystalline toxin was very stable and could be stored for more than 4 years in the refrigerator without change of molecular size (molecular weight, 150,000) and specific activity (307 flocculating units per Am0, 4.2 X 106 50% lethal dose per Am0). The crystalline toxins prepared from the two active fractions from the DE 52 column showed identical properties. The molecular size of the crystalline toxin was different from that reported by Pillemer and Moore (10) . The fragment S was prepared by treating the crystallized tetanus toxin with subtilisin BPN' (subtilisin to the toxin, 1:20, at 370C for 4 h) in 0.05 M Tris-hydrochloride buffer (pH 8.0) and purified from the digest by successive gel filtration (0.05 M Tris-hydrochloride buffer containing 0.15 M NaCl, pH 7.5) on Sephadex G-150 and Sephadex G-100 superfine. The purified fragment S did not show any lethality against mice at an Am0 of 0.01, and its molecular weight was calculated to be 50,000 by gel filtration. As shown in Fig. 2 , fragment S revealed three bands on polyacrylamide gel electrophoresis but a single precipitin line with incomplete or complete fusion with tetanus toxin by double diffusion test against guinea pig antitoxin (AT) or antifragment S (AF), respectively. To obtain antibodies against tetanus toxin and the fragment S, 41 -P~~~~I NOTES 959 guinea pigs were immunized with Formalintreated antigen with aluminum hydroxide gel as adjuvant. Guinea pigs were injected subcutaneously with the tetanus toxoid or the Formalintreated fragment S at A280 of 0.03 and 0.07, respectively. At 6 weeks after the first injection, each animal was given a second injection with half the amount of the first injection and bled 1 week after the second injection. The immunoglobulin fraction of the sera was collected with ammonium sulfate at 33% saturation. Determination of toxin-neutralizing activity of the antibodies was carried out at L+/10 and L+/1,000 levels in mice. Standard tetanus antitoxin calibrated against the international standard was used to calculate international units of the antitoxin. Table 1 summarizes the neutralizing effect of AT or AF on tetanus toxin in mice. The mixtures of diluted AT or AF and the purified toxin of the test doses were incubated for 1 h at room temperature and then injected into the left thigh of five mice. The international units of AT at L+/10 and L+/1,000 levels were calculated to be 1,180 and 584 IU/ml, respectively. The units of AF were calculated in a manner similar to those of AT, although the value may be less accurate because of a difference of avidity of AF; the titers at L+/10 and L+/1,000 levels were 313 and 51 IU/ml, respectively. Either antibody was able to neutralize the toxin in mice, but when doses of the antibody were insufficient to neutralize the test dose of the toxin completely, symptoms in mice injected with AF were different from those injected with AT. In the latter case, typical symptoms of local tetanus were observed, and the severity of symptoms seemed to depend on a dose of the free toxin in the AT-., 1 3 Dead Local aDose of the toxin at L+/10 and L+/1,000 levels contained 4,800 and 24 50% lethal dose mouse, respectively.
b Severity of local tetanus is expressed in numerical values assigned by Mellanby et al. (8) . The severity in the systemic tetanus was determined by rigidity, form, and condition of the mouse and is expressed in the signs from ± to +++. Five mice were used per dose, and each showed the same type and severity of symptoms.
'Photographs of this mouse are shown in Fig. 3 In this systemic tetanus, spastic paralysis of the injected limb was never observed, and systemic rigidity, especially stiffness of abdominal muscle, weight loss, and delay of onset of the first symptoms were characteristics. Purified tetanus toxin was used as the test toxin in this experiment, but the same result was obtained when crude tetanus toxin was used. Fig. 3 shows typical symptoms of the local and the systemic tetanus produced by injection of the toxin with AT and AF, respectively. Blood was taken out of heart of these mice just after death as shown in Table 1 Table 1 (footnote c).
the blood from the mice developing systemic tetanus but not in the others.
It is quite possible that fragment S may correspond to fragment C described by Helting et al (3) . Thus, the resemblance of the symptoms caused by the mixture of toxin and AF to that caused by fragment B (3) could be due to AF neutralizing that portion of the toxin corresponding to fragment C, but not neutralizing that portion corresponding to fragment B. Arguing against this, perhaps, is the fact that a large amount of AF was able to completely neutralize the toxin. Another factor to consider is the avidity of AF. At the injection site in the thigh, AF may neutralize the receptor binding site of the toxin by binding to fragment C (4). This would prevent local symptoms. But if the toxin-AF complex entered the blood, this complex might dissociate to allow free toxin to produce systemic tetanus. In any case, in considering the use of partial antigens as immunizing agents for tetanus, the understanding of the mechanism of development of systemic tetanus may be significant.
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